Calliditas Therapeutics’ 2020 Annual Report Published
Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) today announces that the Annual Report for 2020 now is available at the company’s website: www.calliditas.com. This information is information that Calliditas Therapeutics AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 14:30 CET on April 27, 2021. For further information, please contact: Marie Galay, IR Manager, Calliditas Tel.: +44 79 55 12 98 45, email: marie.galay@calliditas.com About Calliditas Calliditas Therapeutics is a biopharma